Health Economics Outcomes Research (HEOR) is now the key factor in drug utilization and reimbursement. Real-world data are essential to both internal teams and external stakeholders, as it affects every step of the process – from pipeline planning, to R&D;, to commercialization, to reimbursement. This is a unique opportunity for the pharmaceutical industry to re-define the continuum of care and transition to value over volume

Topics Include

• Navigating the New World of Healthcare – A Value-Driven Approach
• Demonstrating Economic and Clinical Value (ECV)
• Methods to Approach the FDA/CMS Parallel Review
• Enhancing the Pharmaceutical/Payer Relationship
• Methods to Eliminate Spending Waste
• Digital Tools to Facilitate Patient and Physician Communication
• Choosing Value Points for Payers, Physicians, and Patients
• Portfolio Prioritization
• Incorporating Personalized Medicine for Better Results
• Utilizing Patient Profiles to Create Better Personalized Care
• The New Role of Engagement Leaders